{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:23:49Z","timestamp":1760189029078},"reference-count":20,"publisher":"BMJ","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives of Disease in Childhood"],"published-print":{"date-parts":[[1983,9,1]]},"DOI":"10.1136\/adc.58.9.703","type":"journal-article","created":{"date-parts":[[2008,12,22]],"date-time":"2008-12-22T21:51:33Z","timestamp":1229982693000},"page":"703-708","source":"Crossref","is-referenced-by-count":49,"title":["Inhibitor of prostacyclin production in sporadic haemolytic uraemic syndrome."],"prefix":"10.1136","volume":"58","author":[{"given":"M","family":"Levin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K B","family":"Elkon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T J","family":"Nokes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A M","family":"Buckle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M J","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R M","family":"Hardisty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T M","family":"Barratt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(78)91573-8","article-title":"Haemolyticuraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity?","volume":"ii:","author":"Remuzzi, G.; Marchesi, D.; Mecca, G.","year":"1978","unstructured":"Remuzzi G, Marchesi D, Mecca G, et al. Haemolyticuraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity? Lancet 1978;ii:871-2.","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/bmj.281.6235.271","article-title":"Prostacyclin deficiency in haemolytic uraemic syndrome","volume":"281","author":"Webster, J.; Rees, A.J.; Lewis, P.J.; Hensby, C.N.","year":"1980","unstructured":"Webster J, Rees AJ, Lewis PJ, Hensby CN. Prostacyclin deficiency in haemolytic uraemic syndrome. Br Med J 1980;281:271.","journal-title":"Br Med J"},{"key":"ref_3","first-page":"661","article-title":"Plasma 6-keto-PGF1 oc levels after plasma exchange in thrombotic thrombocytopenic purpura (letter)","volume":"i:","author":"Machin, S.J.; Defreyn, G.; Chamone, D.A.F.; Vermylen, J.","year":"1980","unstructured":"Machin SJ, Defreyn G, Chamone DAF, Vermylen J. Plasma 6-keto-PGF1 oc levels after plasma exchange in thrombotic thrombocytopenic purpura (letter). Lancet 1980;i:661.","journal-title":"Lancet"},{"key":"ref_4","first-page":"267","article-title":"Accelerated prostacyclin degradation in thrombotic thrombocytopenic purpura","volume":"ii:","author":"Chen, Y.C.; Hall, E.R.; McLeod, B.; Wu, K.K.","year":"1981","unstructured":"Chen YC, Hall ER, McLeod B, Wu KK. Accelerated prostacyclin degradation in thrombotic thrombocytopenic purpura. Lancet 1981;ii:267-9.","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/271549a0","article-title":"Localisation and stimulation of prostacyclin production in vascular cells","volume":"271","author":"Maclntyre, D.E.; Pearson, J.D.; Gordon, J.L.","year":"1978","unstructured":"Maclntyre DE, Pearson JD, Gordon JL. Localisation and stimulation of prostacyclin production in vascular cells. Nature 1978;271:549-51.","journal-title":"Nature"},{"key":"ref_6","first-page":"\"1386","article-title":"Treatment of thrombotic thrombocytopenic purpura with plasma","volume":"297","author":"Byrnes, J.J.; Khurana, M.","year":"1977","unstructured":"Byrnes JJ, Khurana M. Treatment of thrombotic thrombocytopenic purpura with plasma. N Engl J Med 1977; 297:1386-9. 7Anonymous. Plasma exchange in thrombotic thrombocytopenic purpura (Editorial). Lancet 1979;i:1065-6.","journal-title":"N Engl J Med; 7Anonymous. Plasma exchange in thrombotic thrombocytopenic purpura (Editorial"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1055\/s-0038-1653417","article-title":"Normal prostacyclin-like activity in thrombotic thrombocytopenic purpura (letter)","volume":"46","author":"Pini, M.; Manotti, C.; Quintavalla, R.; Dettori, A.G.","year":"1981","unstructured":"Pini M, Manotti C, Quintavalla R, Dettori AG. Normal prostacyclin-like activity in thrombotic thrombocytopenic purpura (letter). Thromb Haemost 1981;46:571.","journal-title":"Thromb Haemost"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0031-3955(16)34216-X","article-title":"Hemolyticuremic syndrome: current concepts and management","volume":"29","author":"Fong, J.S.C.; de Chadarevian, J.P.; Kaplan, B.S.","year":"1982","unstructured":"Fong JSC, de Chadarevian JP, Kaplan BS. Hemolyticuremic syndrome: current concepts and management. Pediatr Clin North Am 1982;29:835-56.","journal-title":"Pediatr Clin North Am"},{"key":"ref_9","first-page":"890","article-title":"Platelets, endothelium and renal disease (Editorial)","volume":"ii:","author":"Anonymous","year":"1979","unstructured":"Anonymous. Platelets, endothelium and renal disease (Editorial). Lancet 1979;ii:890-2.","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/adc.58.2.101","article-title":"Haemolyticuraemic syndrome: an analysis of prognostic features","volume":"58","author":"Trompeter, R.S.; Schwartz, R.; Chantler, C.","year":"1983","unstructured":"Trompeter RS, Schwartz R, Chantler C, et al. Haemolyticuraemic syndrome: an analysis of prognostic features. Arch Dis Child 1983;58:101-5.","journal-title":"Arch Dis Child"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00005792-198111000-00003","article-title":"Thrombotic thrombocytopenic purpura; report of 25 cases and review of the literature","volume":"60","author":"Ridolfi, R.L.; Bell, W.R.","year":"1981","unstructured":"Ridolfi RL, Bell WR. Thrombotic thrombocytopenic purpura; report of 25 cases and review of the literature. Medicine (Baltimore) 1981;60:413-28.","journal-title":"Medicine (Baltimore)"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000180229","article-title":"GE' Sojo ET. The hemolytic-uremic syndrome","volume":"11","author":"Gianantonio, C.A.; Vitacco, M.; Mendilaharzu, F.; Gallo","year":"1973","unstructured":"Gianantonio CA, Vitacco M, Mendilaharzu F, Gallo GE' Sojo ET. The hemolytic-uremic syndrome. Nephron 1973;11:174-92.","journal-title":"Nephron"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0140-6736(77)91655-5","article-title":"Human arterial and venous tissues generate prostacyclin (prostaglandin X), a potent inhibitor of platelet aggregation","volume":"i:","author":"Moncada, S.; Higgs, E.A.; Vane, JR","year":"1977","unstructured":"Moncada S, Higgs EA, Vane JR. Human arterial and venous tissues generate prostacyclin (prostaglandin X), a potent inhibitor of platelet aggregation. Lancet 1977;i: 18-21.","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJM197505222922102","article-title":"Hemolytic uremic syndrome in families","volume":"292","author":"Kaplan, B.S.; Chesney, R.W.; Drummond, K.N.","year":"1975","unstructured":"Kaplan BS, Chesney RW, Drummond KN. Hemolytic uremic syndrome in families. N Engl J Med 1975;292: 1090-3.","journal-title":"N Engl J Med"},{"key":"ref_15","first-page":"99","article-title":"Prognosis of the hemolytic-uremic syndrome in children","volume":"11","author":"Habib, R.; Levy, M.; Gagnadoux, M.F.; Broyer, M.","year":"1982","unstructured":"Habib R, Levy M, Gagnadoux MF, Broyer M. Prognosis of the hemolytic-uremic syndrome in children. Adv Nephrol 1982;11:99-128.","journal-title":"Adv Nephrol"},{"key":"ref_16","first-page":"239","article-title":"Prostacyclin, platelet aggregation and thrombosis","volume-title":"A multi-disciplinary approach","author":"Moncada, S.; Vane, JR","year":"1978","unstructured":"Moncada S, Vane JR. Prostacyclin, platelet aggregation and thrombosis. In: De Gaetano G, Garattini S, eds. Platelets: A multi-disciplinary approach. New York: Raven Press, 1978:239-58."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/S0021-9258(17)30204-1","article-title":"Peroxidase-dependent deactivation of prostacyclin synthetase","volume":"254","author":"Ham, E.A.; Egan, R.W.; Soderman, D.D.; Gale, P.H.; Kuehl, Jr, F.A.","year":"1979","unstructured":"Ham EA, Egan RW, Soderman DD, Gale PH, Kuehl FA, Jr. Peroxidase-dependent deactivation of prostacyclin synthetase. J Biol Chem 1979;254:2191-94.","journal-title":"J Biol Chem"},{"key":"ref_18","first-page":"14","article-title":"Red cell membrane phospholipid abnormalities in the hemolytic-uremic syndrome","volume":"15","author":"O'Regan, S.; Chesney, R.W.; Kaplan, B.S.; Drummond, K.N.","year":"1980","unstructured":"O'Regan S, Chesney RW, Kaplan BS, Drummond KN. Red cell membrane phospholipid abnormalities in the hemolytic-uremic syndrome. Clin Nephrol 1980;15:14-7.","journal-title":"Clin Nephrol"},{"key":"ref_19","first-page":"181","article-title":"Erythrocyte syperoxide dismutase activity in hemolytic-uremic syndrome","volume":"27","author":"Kobayashi, Y.; Okahata, S.; Tanabe, K.; Tanaka, Y.; Veda, K.; Usui, T.","year":"1978","unstructured":"Kobayashi Y, Okahata S, Tanabe K, Tanaka Y, Veda K, Usui T. Erythrocyte syperoxide dismutase activity in hemolytic-uremic syndrome. Hiroshima J Med Sci 1978;27:181-3.","journal-title":"Hiroshima J Med Sci"},{"key":"ref_20","first-page":"273","article-title":"Hemolyticuremic syndrome, prostaglandins and plasma factors","volume-title":"prostaglandins and renal diseases","author":"Donati, M.N.; Misiani, R.; Marchesi, D.","year":"1980","unstructured":"Donati MN, Misiani R, Marchesi D, et al. Hemolyticuremic syndrome, prostaglandins and plasma factors. In: Remuzzi G, Mecca G, De Gaetano G, eds. Hemostasis, prostaglandins and renal diseases. New York: Raven Press, 1980:273-90."}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/adc.58.9.703","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T16:29:31Z","timestamp":1632846571000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/adc.58.9.703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,9,1]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1983,9,1]]}},"URL":"https:\/\/doi.org\/10.1136\/adc.58.9.703","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983,9,1]]}}}